Pfizer Strikes Deal With Impax Over Generic Detrol LA
Drug makers Pfizer Inc. and Impax Laboratories Inc have settled patent litigation over Impax's bid to produce a generic version of Pfizer's overactive-bladder drug Detrol LA, according to court papers filed...To view the full article, register now.
Already a subscriber? Click here to view full article